Your Health, We Care
Release date: 2026-01-05 14:45:06 Recommended: 1
Indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage, late-stage, or metastatic breast cancer in adults.
